Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
about
Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study groupRelapsed acute myeloid leukemia: why is there no standard of care?Primary refractory acute myeloid leukaemia - in search of better definitions and therapies.Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.Salvage therapy for relapsed or refractory acute myeloid leukemiaRandomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes.Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia.Results of treatment of acute myeloid leukemia in central part of IranLate-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia.Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensusMesenchymal stromal cells contribute to quiescence of therapy resistant leukemic cells in acute myeloid leukemia.Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia.Day 14 bone marrow examination in the management of acute myeloid leukemia.Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CTControl of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant.Enhanced sensitivity to glucocorticoids in cytarabine-resistant AMLLong-term outcomes for patients with acute myeloid leukemia: a single-center experience from AIIMS, India.Expert insights into the contemporary management of older adults with acute myeloid leukemia.Determinants of 1-year survival in critically ill acute leukemia patients: a GRRR-OH study.Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia.
P2860
Q33392185-1482A27B-8ED4-4681-9AD3-145E45A79CD2Q33558123-DB0940F1-A686-4FE5-A32E-0D7621ADBCEEQ33877202-2A3C15EB-694D-4055-96D3-36E92F8D0ECBQ33877213-57A797C2-A8DE-4CE0-AE2F-95AF4179B157Q34979564-2FE6E9E6-3316-4E18-A120-FE8D2B7E897FQ35539493-27F008CC-2E2F-43D4-B2A5-614C0478BBF8Q36208652-79B7544C-E86A-43E9-8AF2-794205007C16Q36612564-C28D0419-6E92-4517-9FB5-54FA9DE8B96CQ36709001-A913BCBD-1C52-43F8-B418-E23C9811F5A4Q37075666-4F3414E4-1582-4E7B-A4DD-DD6B93437B5EQ37120335-D93E58F5-21A2-4B94-9A04-94B046698D9FQ37526840-D57C2879-11D7-4C8A-A5FA-C1A72B13CD67Q38042705-E0ABCE00-3620-495A-BA6F-CC650BFD488DQ38044773-15DD7CF9-A312-4AB3-B70D-91F5CA110419Q38106983-BA3A0EFD-BEC3-4F86-9C98-4C5C2152EE02Q38628894-0D36D93D-FE97-4AAE-BB40-6956C39BB6E7Q38668301-E62F14E3-BBA8-4E47-ADE4-507D6CB714FCQ38916984-554BBA5E-C1C6-47C6-BD44-50E252B8661FQ39071892-19144A21-4052-4AE9-879E-3BF32B876807Q39135512-31029755-8A0D-4F05-85F7-9B364290C1BFQ39371569-FD1626F1-1552-409A-9667-E956E4A48D63Q39406956-3C9D7174-42AF-4B3B-AF44-DC26A18150F3Q39475017-6E0521FF-1ECA-4FBE-A523-378921FEFE61Q41683904-6A23CC4F-65E8-4CE3-9FE2-597BD394EA48Q41715517-CC491DEF-F13D-420F-A0E9-F0A85417A85DQ42287089-D3B096C0-CE54-43F6-874C-B6DD6E30D592Q44635019-5CDD4191-20A7-4E0C-8F0E-1D4AD551D4B4Q44898238-774A3607-0BF6-497D-8034-5DFED8E73FD9Q47774723-A079D3FA-18C1-409F-964C-774D6ED51C8CQ50928096-F1C2B33C-C3C1-45D3-B625-2EFB9667A6FFQ52873870-3D61EC2C-1C8F-4ED9-89D2-3F133140C1D7Q53389536-B32360BE-5022-4E20-A21C-325DB5E5F48EQ54363661-88446351-0494-41A5-B295-8D1E8A5DDEDF
P2860
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@ast
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@en
type
label
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@ast
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@en
prefLabel
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@ast
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@en
P2093
P2860
P356
P1433
P1476
Adult patients with acute myel ...... rn Cooperative Oncology Group.
@en
P2093
Haesook T Kim
Jacob M Rowe
Mark R Litzow
Peter A Cassileth
Peter H Wiernik
P2860
P304
P356
10.1002/CNCR.25263
P407
P577
2010-11-01T00:00:00Z